We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Pathology Differences Distinguish CTE from Azheimer's Disease

By LabMedica International staff writers
Posted on 01 Apr 2019
Print article
Image: These images highlight the differences found in the tau folds associated with Alzheimer\'s disease and Chronic Traumatic Encephalopathy (CTE). They also show an unidentified element found in CTE that does not exist in Alzheimer\'s disease (Photo courtesy of Indiana University School of Medicine).
Image: These images highlight the differences found in the tau folds associated with Alzheimer\'s disease and Chronic Traumatic Encephalopathy (CTE). They also show an unidentified element found in CTE that does not exist in Alzheimer\'s disease (Photo courtesy of Indiana University School of Medicine).
Neurological disease researchers have found an important difference that distinguishes the molecular pathology of Chronic Traumatic Encephalopathy (CTE) from that of Alzheimer's disease (AD).

CTE is a neurodegenerative tauopathy - a pathological aggregation of tau protein in neurofibrillary or gliofibrillary tangles in the brain - that is associated with repetitive head impacts or exposure to blast waves. It was described first as "punch-drunk syndrome" and dementia pugilistica in retired boxers, but has since been identified in former participants of other contact sports, ex-military personnel, and after physical abuse. No disease-modifying therapies currently exist, and diagnosis requires an autopsy. In AD, tau undergoes chemical changes, becoming hyperphosphorylated; it then begins to pair with other threads, creating neurofibrillary tangles and disintegrating the neuron's transport system.

Investigators at Indiana University School of Medicine (Indianapolis, USA) used cryo-electron microscopy (cryo-EM) to demonstrate a fundamental difference between the tau tangles of CTE and those of AD. Cryo-EM is an analytical technique that provides near-atomic structural resolution without requirements for crystallization or limits on molecular size and complexity imposed by the other techniques. Cryo-EM allows the observation of specimens that have not been stained or fixed in any way, showing them in their native environment while integrating multiple images to form a three-dimensional model of the sample.

The investigators determined the structures of tau filaments from the brains of three individuals with CTE at resolutions down to 2.3 Angstroms, using cryo-electron microscopy. They showed that filament structures were identical in the three cases but were distinct from those of Alzheimer’s and Pick’s diseases, and from those formed in vitro. In CTE, a different conformation of the beta-helix region created a hydrophobic cavity that was absent in tau filaments from the brains of patients with Alzheimer’s disease. This cavity enclosed an additional density that was not connected to tau, which suggested that the incorporation of cofactors may have a role in tau aggregation in CTE. The discovery of the difference between pathogenic tau of CTE and that of AD offers options for improved diagnosis and potential targeted treatments.

Contributing author Dr. Ruben Vidal, professor in the of pathology and laboratory medicine at Indiana University School of Medicine, said, "These two new discoveries provide more insights into CTE than had previously existed. The information will be incredibly valuable for the development of novel agents to help in diagnosis and therapeutics specifically designed for individuals fighting CTE."

The cryo-EM study was published in the March 20, 2019, online edition of the journal Nature.

Related Links:
Indiana University School of Medicine

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.